ClinicalTrials.gg

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Imunopharm Technology Co., Ltd. clinical trials

Also known as Immunochina, Yimiao Shenzhou.

The registry lists 27 studies whose lead sponsor is Imunopharm Technology Co., Ltd. or one of 1 company grouped under it. 10 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 13, 2026.

Keep track of what changes. Save the Imunopharm Technology Co., Ltd. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Status unknown
15
Not yet recruiting
8
Recruiting
2
Completed
2

Phase

Phase 1
18
Early Phase 1
8
Phase 2
6

Where

China
20

Registry sponsor names on this page

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Imunopharm Technology Co., Ltd..

  • Beijing Immunochina Medical Science & Technology Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    27 studies →

Studies

Recruiting first, then most recently updated. Showing 27 of 27.